Bilastine is a novel antihistamine molecule which is non-sedative
Size: 212.76 KB
Language: en
Added: Jan 09, 2022
Slides: 2 pages
Slide Content
Bilastine and Quality of Life
Article published in the Journal of Instigative Allergology and Clinical Immunology
in the Year 2011.
Introduction
Quality of Life is particularly important in many allergic disorders, and in particular
in urticaria.
Objective of the Study
To evaluate the Quality of Life in the development of antihistamines, as Bilastine
is the most commonly used drugs in application to the most prevalent allergic
disorders.
Bilastine and Quality of Life in Chronic Urticaria
Bilastine in a single daily dose of 20 mg has been shown to be more
effective than placebo and as effective as cetirizine, fexofenadine and
desloratadine.
Bilastine contributes to improve the HRQoL in patients with chronic
urticaria, at least in the context of the analyzed clinical trial.
In a total of 525 patients – Bilastine showed improvement in all the
Dermatology Life Quality Index domains for both active drug groups, in
resulted to the decrease in itching and in the number and size of the
wheals